Full text is available at the source.
Novel Furan Coupled Quinoline Diamide Hybrid Scaffolds as Potent Antitubercular Agents: Design, Synthesis and Molecular Modelling
New Furan-Quinoline Compounds Designed and Tested as Powerful Tuberculosis Treatments
AI simplified
Abstract
Compounds exhibited antitubercular activity with inhibition concentrations ranging from 1.6 to 12 µg/ml.
- The synthesized compounds inhibited the growth of the H37Rv strain of Mycobacterium tuberculosis.
- Molecular docking studies indicated that furan, quinoline, and diamide derivatives fit well within the binding domains of target proteins.
- Certain compounds, specifically 5f, 5b, and 8a, demonstrated particularly strong inhibition activity.
- The presence of three different chemical structures in these compounds may allow them to act on multiple targets.
- This research suggests potential pathways for novel drug discovery in tuberculosis treatment.
AI simplified